| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy.
|
Proc Natl Acad Sci U S A
|
2008
|
5.18
|
|
2
|
Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer.
|
J Clin Oncol
|
2005
|
5.10
|
|
3
|
KIF5B-RET fusions in lung adenocarcinoma.
|
Nat Med
|
2012
|
4.38
|
|
4
|
A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.
|
Cancer Res
|
2013
|
3.08
|
|
5
|
Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas.
|
Cancer Res
|
2011
|
2.81
|
|
6
|
Comprehensive histologic analysis of ALK-rearranged lung carcinomas.
|
Am J Surg Pathol
|
2011
|
2.21
|
|
7
|
Histopathologic prognostic factors in resected colorectal lung metastases.
|
Ann Thorac Surg
|
2005
|
1.71
|
|
8
|
High-grade lung adenocarcinoma with fetal lung-like morphology: clinicopathologic, immunohistochemical, and molecular analyses of 17 cases.
|
Am J Surg Pathol
|
2013
|
1.53
|
|
9
|
ROS1-rearranged lung cancer: a clinicopathologic and molecular study of 15 surgical cases.
|
Am J Surg Pathol
|
2013
|
1.52
|
|
10
|
A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population.
|
Nat Genet
|
2012
|
1.51
|
|
11
|
EGFR mutations predict survival benefit from gefitinib in patients with advanced lung adenocarcinoma: a historical comparison of patients treated before and after gefitinib approval in Japan.
|
J Clin Oncol
|
2008
|
1.50
|
|
12
|
Epidermal growth factor receptor mutation status and clinicopathological features of combined small cell carcinoma with adenocarcinoma of the lung.
|
Cancer Sci
|
2007
|
1.47
|
|
13
|
Novel use for an EGFR mutation-specific antibody in discriminating lung adenocarcinoma from reactive pneumocyte hyperplasia.
|
Histopathology
|
2015
|
1.41
|
|
14
|
STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors.
|
Am J Surg Pathol
|
2014
|
1.41
|
|
15
|
Detection of EGFR mutations in archived cytologic specimens of non-small cell lung cancer using high-resolution melting analysis.
|
Am J Clin Pathol
|
2006
|
1.36
|
|
16
|
Epidermal growth factor receptor mutation detection using high-resolution melting analysis predicts outcomes in patients with advanced non small cell lung cancer treated with gefitinib.
|
Clin Cancer Res
|
2007
|
1.34
|
|
17
|
Prospective study of the accuracy of EGFR mutational analysis by high-resolution melting analysis in small samples obtained from patients with non-small cell lung cancer.
|
Clin Cancer Res
|
2008
|
1.31
|
|
18
|
Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors.
|
J Neurooncol
|
2008
|
1.28
|
|
19
|
Genome-wide identification of genes with amplification and/or fusion in small cell lung cancer.
|
Genes Chromosomes Cancer
|
2013
|
1.23
|
|
20
|
Bright-field dual-color chromogenic in situ hybridization for diagnosing echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase-positive lung adenocarcinomas.
|
J Thorac Oncol
|
2011
|
1.23
|
|
21
|
Frequent ALK rearrangement and TTF-1/p63 co-expression in lung adenocarcinoma with signet-ring cell component.
|
Lung Cancer
|
2010
|
1.21
|
|
22
|
Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma.
|
Mod Pathol
|
2006
|
1.12
|
|
23
|
Minute pulmonary meningothelial-like nodules: clinicopathologic analysis of 121 patients.
|
Hum Pathol
|
2009
|
1.11
|
|
24
|
The usefulness of mutation-specific antibodies in detecting epidermal growth factor receptor mutations and in predicting response to tyrosine kinase inhibitor therapy in lung adenocarcinoma.
|
Lung Cancer
|
2010
|
1.10
|
|
25
|
Multiple lung adenocarcinomas showing ground-glass opacities on thoracic computed tomography.
|
Ann Thorac Surg
|
2006
|
1.10
|
|
26
|
RET fusion gene: translation to personalized lung cancer therapy.
|
Cancer Sci
|
2013
|
1.09
|
|
27
|
Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2/neu-positive breast cancer.
|
Cancer
|
2010
|
1.09
|
|
28
|
Oncogenic mutation of PIK3CA in small cell lung carcinoma: a potential therapeutic target pathway for chemotherapy-resistant lung cancer.
|
Cancer Lett
|
2009
|
1.08
|
|
29
|
Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors.
|
Arch Pathol Lab Med
|
2008
|
1.07
|
|
30
|
Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung.
|
Lung Cancer
|
2005
|
1.06
|
|
31
|
Immunohistochemical expression of PTEN and phosphorylated Akt are not correlated with clinical outcome in breast cancer patients treated with trastuzumab-containing neo-adjuvant chemotherapy.
|
Med Oncol
|
2008
|
1.05
|
|
32
|
MYC amplification as a prognostic marker of early-stage lung adenocarcinoma identified by whole genome copy number analysis.
|
Clin Cancer Res
|
2010
|
1.03
|
|
33
|
Histological scoring for small lung adenocarcinomas 2 cm or less in diameter: a reliable prognostic indicator.
|
J Thorac Oncol
|
2010
|
1.03
|
|
34
|
Aberrant anaplastic lymphoma kinase expression in high-grade pulmonary neuroendocrine carcinoma.
|
J Clin Pathol
|
2013
|
1.01
|
|
35
|
DNA methylation profiles at precancerous stages associated with recurrence of lung adenocarcinoma.
|
PLoS One
|
2013
|
1.00
|
|
36
|
Regulatory nexus of synthesis and degradation deciphers cellular Nrf2 expression levels.
|
Mol Cell Biol
|
2013
|
1.00
|
|
37
|
Association of DNA repair gene polymorphisms with response to platinum-based doublet chemotherapy in patients with non-small-cell lung cancer.
|
J Clin Oncol
|
2010
|
1.00
|
|
38
|
Prognostic implication of metastasis limited to segmental (level 13) and/or subsegmental (level 14) lymph nodes in patients with surgically resected nonsmall cell lung carcinoma and pathologic N1 lymph node status.
|
Cancer
|
2012
|
1.00
|
|
39
|
Proteomic signature corresponding to the response to gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinoma.
|
Clin Cancer Res
|
2007
|
0.99
|
|
40
|
Dominant papillary subtype is a significant predictor of the response to gefitinib in adenocarcinoma of the lung.
|
Clin Cancer Res
|
2004
|
0.99
|
|
41
|
Primary pulmonary adenocarcinoma with enteric differentiation resembling metastatic colorectal carcinoma: a report of the second case negative for cytokeratin 7.
|
Pathol Res Pract
|
2010
|
0.98
|
|
42
|
NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma.
|
Am J Surg Pathol
|
2012
|
0.98
|
|
43
|
Development and validation of diagnostic prediction model for solitary pulmonary nodules.
|
Respirology
|
2007
|
0.98
|
|
44
|
Predictive factors for local recurrence of resected colorectal lung metastases.
|
Ann Thorac Surg
|
2005
|
0.97
|
|
45
|
Whole genome comparison of allelic imbalance between noninvasive and invasive small-sized lung adenocarcinomas.
|
Cancer Res
|
2009
|
0.95
|
|
46
|
Immunohistochemical profiles of brain metastases from breast cancer.
|
J Neurooncol
|
2008
|
0.94
|
|
47
|
Expression of the GA733 gene family and its relationship to prognosis in pulmonary adenocarcinoma.
|
Virchows Arch
|
2010
|
0.94
|
|
48
|
SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis.
|
Mod Pathol
|
2013
|
0.94
|
|
49
|
New methods for ALK status diagnosis in non-small-cell lung cancer: an improved ALK immunohistochemical assay and a new, Brightfield, dual ALK IHC-in situ hybridization assay.
|
J Thorac Oncol
|
2013
|
0.94
|
|
50
|
Identification of a lung adenocarcinoma cell line with CCDC6-RET fusion gene and the effect of RET inhibitors in vitro and in vivo.
|
Cancer Sci
|
2013
|
0.93
|
|
51
|
Epigenetic clustering of lung adenocarcinomas based on DNA methylation profiles in adjacent lung tissue: Its correlation with smoking history and chronic obstructive pulmonary disease.
|
Int J Cancer
|
2014
|
0.93
|
|
52
|
Prognostic significance of RNA-dependent protein kinase on non-small cell lung cancer patients.
|
Clin Cancer Res
|
2010
|
0.91
|
|
53
|
Successful resection of dermatomyositis associated with thymic carcinoma: report of a case.
|
Surg Today
|
2008
|
0.91
|
|
54
|
Immunohistochemical differential diagnosis between large cell neuroendocrine carcinoma and small cell carcinoma by tissue microarray analysis with a large antibody panel.
|
Am J Clin Pathol
|
2006
|
0.91
|
|
55
|
Nuclear grading of primary pulmonary adenocarcinomas: correlation between nuclear size and prognosis.
|
Cancer
|
2010
|
0.90
|
|
56
|
Clinicopathologic analysis of multiple (five or more) atypical adenomatous hyperplasias (AAHs) of the lung: evidence for the AAH-adenocarcinoma sequence.
|
J Thorac Oncol
|
2010
|
0.89
|
|
57
|
Adenocarcinoma of the thymus: mucinous subtype.
|
Hum Pathol
|
2005
|
0.88
|
|
58
|
Ciliated muconodular papillary tumors of the lung: a clinicopathologic analysis of 10 cases.
|
Am J Surg Pathol
|
2015
|
0.88
|
|
59
|
Effect of platinum combined with irinotecan or paclitaxel against large cell neuroendocrine carcinoma of the lung.
|
Jpn J Clin Oncol
|
2007
|
0.88
|
|
60
|
Mouse model for ROS1-rearranged lung cancer.
|
PLoS One
|
2013
|
0.88
|
|
61
|
Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing.
|
J Thorac Oncol
|
2015
|
0.87
|
|
62
|
p40 is the best marker for diagnosing pulmonary squamous cell carcinoma: comparison with p63, cytokeratin 5/6, desmocollin-3, and sox2.
|
Appl Immunohistochem Mol Morphol
|
2014
|
0.87
|
|
63
|
Prognostic factors for malignant pericardial effusion treated by pericardial drainage in solid-malignancy patients.
|
Med Oncol
|
2007
|
0.87
|
|
64
|
ECT2 amplification and overexpression as a new prognostic biomarker for early-stage lung adenocarcinoma.
|
Cancer Sci
|
2014
|
0.86
|
|
65
|
Molecular markers and changes of computed tomography appearance in lung adenocarcinoma with ground-glass opacity.
|
Jpn J Clin Oncol
|
2007
|
0.86
|
|
66
|
Molecular mechanisms underlying oncogenic RET fusion in lung adenocarcinoma.
|
J Thorac Oncol
|
2014
|
0.85
|
|
67
|
Does the mode of surgical resection affect the prognosis/recurrence in patients with thymoma?
|
J Surg Oncol
|
2013
|
0.85
|
|
68
|
Clinicopathological analysis of primary lung carcinoma with heterotopic ossification.
|
Lung Cancer
|
2008
|
0.85
|
|
69
|
Combination chemotherapy with carboplatin and paclitaxel for advanced thymic cancer.
|
Jpn J Clin Oncol
|
2011
|
0.85
|
|
70
|
Amrubicin monotherapy for patients with previously treated advanced large-cell neuroendocrine carcinoma of the lung.
|
Jpn J Clin Oncol
|
2011
|
0.84
|
|
71
|
Expression of squamous cell carcinoma markers and adenocarcinoma markers in primary pulmonary neuroendocrine carcinomas.
|
Appl Immunohistochem Mol Morphol
|
2013
|
0.84
|
|
72
|
Anaplastic lymphoma kinase status in rhabdomyosarcomas.
|
Mod Pathol
|
2013
|
0.84
|
|
73
|
Immunohistochemical expression of TTF-1 in various cytological subtypes of primary lung adenocarcinoma, with special reference to intratumoral heterogeneity.
|
Pathol Int
|
2008
|
0.83
|
|
74
|
Malignant pulmonary epithelioid hemangioendothelioma with hilar lymph node metastasis.
|
Ann Diagn Pathol
|
2010
|
0.83
|
|
75
|
Pleuroscopic punch biopsy using insulated-tip diathermic knife-2 for the diagnosis of desmoplastic malignant mesothelioma.
|
J Bronchology Interv Pulmonol
|
2013
|
0.83
|
|
76
|
Immunohistochemical expression of HER1, HER3, and HER4 in HER2-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy.
|
J Surg Oncol
|
2010
|
0.83
|
|
77
|
Contrasting prognostic implications of platelet-derived growth factor receptor-β and vascular endothelial growth factor receptor-2 in patients with angiosarcoma.
|
Ann Surg Oncol
|
2011
|
0.82
|
|
78
|
Prognostic impact of pleural invasion in 1488 patients with surgically resected non-small cell lung carcinoma.
|
Jpn J Clin Oncol
|
2013
|
0.82
|
|
79
|
Histological evaluation of the effect of smoking on peripheral small adenocarcinomas of the lung.
|
J Thorac Oncol
|
2008
|
0.81
|
|
80
|
Desmoplastic small round cell tumor with sphere-like clusters mimicking adenocarcinoma.
|
Diagn Cytopathol
|
2014
|
0.80
|
|
81
|
Non-invasive X-ray micro-computed tomographic evaluation of indomethacin on urethane-induced lung carcinogenesis in mice.
|
Anticancer Res
|
2012
|
0.79
|
|
82
|
Cytopathologic factors can predict invasion in small-sized peripheral lung adenocarcinoma with a bronchioloalveolar carcinoma component.
|
Cancer
|
2006
|
0.79
|
|
83
|
Steroid receptor expression in thymomas and thymic carcinomas.
|
Cancer
|
2011
|
0.79
|
|
84
|
Inflammatory myofibroblastic tumour of the lung with a novel PPFIBP1-ALK fusion variant.
|
Histopathology
|
2013
|
0.79
|
|
85
|
Combined high-grade neuroendocrine carcinoma of the lung: clinicopathological and immunohistochemical study of 34 surgically resected cases.
|
Pathol Int
|
2014
|
0.79
|
|
86
|
Proteomic study of malignant pleural mesothelioma by laser microdissection and two-dimensional difference gel electrophoresis identified cathepsin D as a novel candidate for a differential diagnosis biomarker.
|
J Proteomics
|
2011
|
0.78
|
|
87
|
Differences in clinicopathological and biological features between central-type and peripheral-type squamous cell carcinoma of the lung.
|
Lung Cancer
|
2006
|
0.78
|
|
88
|
BRAF V600 mutations and pathological features in Japanese melanoma patients.
|
Melanoma Res
|
2015
|
0.78
|
|
89
|
Recycling and long-term storage of fluorescence in situ hybridization slides.
|
Am J Clin Pathol
|
2014
|
0.77
|
|
90
|
Association of CYP19A1 polymorphisms with risks for atypical adenomatous hyperplasia and bronchioloalveolar carcinoma in the lungs.
|
Carcinogenesis
|
2010
|
0.76
|
|
91
|
Cathepsin D as a potential prognostic marker for lung adenocarcinoma.
|
Pathol Res Pract
|
2012
|
0.76
|
|
92
|
Comparison between whole mount tissue preparations and virtual tissue microarray samples for measuring Ki-67 and apoptosis indices in human bladder cancer: A cross-sectional study.
|
Medicine (Baltimore)
|
2016
|
0.75
|
|
93
|
Correction: Ultra-High-Resolution Computed Tomography of the Lung: Image Quality of a Prototype Scanner.
|
PLoS One
|
2015
|
0.75
|
|
94
|
Utility of PAX8 mouse monoclonal antibody in the diagnosis of thyroid, thymic, pleural and lung tumours: a comparison with polyclonal PAX8 antibody.
|
Histopathology
|
2014
|
0.75
|
|
95
|
[Feasibility Study for Storage and Re-Utilization of Circulating Tumor Cells (CTCs)].
|
Rinsho Byori
|
2015
|
0.75
|
|
96
|
Pulmonary neuroendocrine tumors with nuclear inclusion.
|
Pathol Res Pract
|
2013
|
0.75
|
|
97
|
Secondary osteosarcoma developing 10 years after chemoradiotherapy for non-small-cell lung cancer.
|
Jpn J Clin Oncol
|
2013
|
0.75
|
|
98
|
Centrally located adenocarcinoma with endobronchial polypoid growth: clinicopathological analysis of five cases.
|
Pathol Int
|
2010
|
0.75
|
|
99
|
[Challenges and Outcomes of the Process for Achieving Certification].
|
Rinsho Byori
|
2016
|
0.75
|
|
100
|
Myocardial Sleeve Tissues in Surgical Lung Specimens.
|
Am J Surg Pathol
|
2015
|
0.75
|
|
101
|
A case of malignant pleural mesothelioma with osseous and cartilaginous differentiation.
|
J Thorac Imaging
|
2011
|
0.75
|
|
102
|
[Pulmonary epithelioid hemangioendothelioma].
|
Kyobu Geka
|
2013
|
0.75
|
|
103
|
Sarcomatoid malignant pleural mesothelioma confirmed by full-thickness biopsy.
|
Chin Med J (Engl)
|
2013
|
0.75
|
|
104
|
SPECT/CT of lung nodules using 111In-DOTA-c(RGDfK) in a mouse lung carcinogenesis model.
|
Ann Nucl Med
|
2013
|
0.75
|